Dixon Hubard Feinour & Brown’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$19.4M Sell
94,867
-1,005
-1% -$213K 2.31% 3
2022
Q1
$22.8M Buy
95,872
+35,561
+59% +$8.35M 2.28% 3
2021
Q4
$13.8M Buy
+60,311
New +$13.3M 1.33% 17

Other funds holding CME

Dixon Hubard Feinour & Brown's CME Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown reduced its CME Group (CME) stake by 1% in Q2 2022, selling an estimated $213K and leaving 94,867 shares worth $19.4M. The position accounts for 2.31% of the portfolio, ranked #3.

Dixon Hubard Feinour & Brown first reported a position in CME in Q4 2021 and has held it in 3 quarters since. The position peaked at $22.8M in Q1 2022. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 94,867 shares of CME Group worth $19.4M as of Q2 2022.
  • Dixon Hubard Feinour & Brown sold 1,005 CME Group shares in Q2 2022, an estimated $213K.
  • CME Group made up 2.31% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #3 holding.
  • Dixon Hubard Feinour & Brown first reported a position in CME Group in Q4 2021 and has held it in 3 quarters since.
  • Dixon Hubard Feinour & Brown's CME Group position peaked at $22.8M in Q1 2022.
  • 1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.